Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 13 de 13
Filtre
1.
Electron. j. biotechnol ; 30: 39-47, nov. 2017. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1021362

Résumé

Background: Juvenile Yoshitomi tilapia is often infected by pathogens and results in low-level survival rate. Bacillus subtilis, as a probiotic, may have beneficial effects on Y. tilapia with compound 1-deoxynojirimycin (DNJ), which has antibacterial activities. The effects of dietary probiotic supplementation on Y. tilapias were evaluated. Results: Juvenile Y. tilapia was fed with B. subtilis for 56 d. Y. tilapia was infected by Aeromonas hydrophila and survival rate was compared. Dietary B. subtilis increased weight gain rate, specific growth, food conversion ratios and food intake rate of Y. tilapia. The diet improved the cumulative survival rate (CSR) of juvenile Y. tilapia when the concentration of B. subtilis was more than 2.05 × 1010 cfu/kg and CSR reached a maximum rate when the concentration of bacillus was 4.23 × 1010 (P b 0.05). Meanwhile, B. subtilis improved total antioxidant capacity (TAC), spleen index, the activities of serum lysozyme, alkaline phosphatase (ALP), superoxide dismutase (SOD) and catalase (CAT) (P b 0.05). In contrast, B. subtilis reduced serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), malondialdehyde (MDA) and C3 complement (P b 0.05). DNJ was isolated from secondary metabolisms and proved to increase the levels of SOD, CAT and reduce the levels of AST, ALT and MDA at cell levels. After A. hydrophila infection, DNJ prevented the reduction in survival rate of Y. tilapia (P b 0.05). Conclusions: 1-Deoxynojirimycin from Bacillus subtilis can be used to improve the growth performance of juvenile Y. tilapia by affecting its antioxidant and antibacterial activities.


Sujets)
1-Désoxynojirimycine/administration et posologie , Tilapia/croissance et développement , Tilapia/métabolisme , Probiotiques/administration et posologie , Superoxide dismutase/effets des médicaments et des substances chimiques , Survie , Aeromonas hydrophila/métabolisme , Aquaculture , Phosphatase alcaline/effets des médicaments et des substances chimiques , Antibactériens/métabolisme , Antioxydants/métabolisme
2.
Braz. j. microbiol ; 45(2): 721-729, Apr.-June 2014. ilus, graf, tab
Article Dans Anglais | LILACS | ID: lil-723139

Résumé

DNJ, an inhibitor of α-glucosidase, is used to suppress the elevation of postprandial hyperglycemia. In this study, we focus on screening an appropriate microorganism for performing fermentation to improve DNJ content in mulberry leaf. Results showed that Ganoderma lucidum was selected from 8 species and shown to be the most effective in improvement of DNJ production from mulberry leaves through fermentation. Based on single factor and three factor influence level tests by following the Plackett-Burman design, the optimum extraction yield was analyzed by response surface methodology (RSM). The extracted DNJ was determined by reverse-phase high performance liquid chromatograph equipped with fluorescence detector (HPLC-FD). The results of RSM showed that the optimal condition for mulberry fermentation was defined as pH 6.97, potassium nitrate content 0.81% and inoculums volume 2 mL. The extraction efficiency reached to 0.548% in maximum which is 2.74 fold of those in mulberry leaf.


Sujets)
1-Désoxynojirimycine/isolement et purification , 1-Désoxynojirimycine/métabolisme , Antienzymes/isolement et purification , Antienzymes/métabolisme , Morus/métabolisme , Reishi/métabolisme , Biotechnologie/méthodes , Chromatographie en phase liquide à haute performance , Milieux de culture/composition chimique , Fermentation , Concentration en ions d'hydrogène , Feuilles de plante/métabolisme , Reishi/croissance et développement , Technologie pharmaceutique/méthodes
3.
Journal of Biomedical Research ; : 40-46, 2013.
Article Dans Coréen | WPRIM | ID: wpr-87600

Résumé

The anti-diabetes mechanism of silkworm Bombyx mori L. powder and extracts was found to inhibit the activity of alpha-glycosidase. The major functional component of silkworm powder was 1-deoxynojirimycin (1-DNJ), which exerts a blood glucose-lowering effect. In this study, we aimed to compare the effects of the supplements, including red ginseng extract on the functional components of silkworm. Fifty silkworm larvae were divided into the control group (Con, N=50), group A (A, artificial diet 95% and mulberry leaf powder 5%), group B (B, artificial diet 95% and mulberry powder 5%), group C (C, artificial diet 95% and Rubus coreanus remainders 5%), group D (D, artificial diet 95% and red ginseng extract 5%), and group E (E, artificial diet 95% and yeast powder (Saccharomyces cerevisiae). Body weights and length of silkworm larvae showed significant improvement in group A, D. In particular, the growth rate in group D (artificial diet 95% and red ginseng extract 5%) was larger than that of Con. In addition, the results showed that 1-DNJ concentration was significantly largest in group D. From these results, it is concluded that the addition of red ginseng extract may be effective for larval growth and 1-DNJ accumulation in silkworm rearing with an artificial diet.


Sujets)
1-Désoxynojirimycine , Poids , Bombyx , Régime alimentaire , Larve , Morus , Panax , Levures
4.
Toxicological Research ; : 263-278, 2013.
Article Dans Anglais | WPRIM | ID: wpr-167293

Résumé

The silkworm extract powder contain 1-deoxynojirimycin (DNJ), a potent alpha-glycosidase inhibitor, has therapeutic potency against diabetes mellitus. Therefore, natural products containing DNJ from mulberry leaves and silkworm are consumed as health functional food. The present study was performed to evaluate the safety of the silkworm extract powder, a health food which containing the DNJ. The repeated toxicity studies and gentic toxicity studies of the silkworm extract powder were performed to obtain the data for new functional food approval in MFDS. The safety was evaluated by a single-dose oral toxicity study and a 90 day repeated-dose oral toxicity study in Sprague-Dawley rats. The silkworm extract powder was also evaluated for its mutagenic potential in a battery of genetic toxicity test: in vitro bacterial reverse mutation assay, in vitro chromosomal aberration test, and in vivo mouse bone marrow micronucleus assay. The results of the genetic toxicology assays were negative in all of the assays. The approximate lethal dose in single oral dose toxicity study was considered to be higher than 5000 mg/kg in rats. In the 90 day study, the dose levels were wet at 0, 500, 1000, 2000 mg/kg/day, and 10 animals/sex/dose were treated with oral gavage. The parameters that were monitored were clinical signs, body weights, food and water consumptions, ophthalmic examination, urinalysis, hematology, serum biochemistry, necropsy findings, organ weights, and histopathological examination. No adverse effects were observed after the 90 day administration of the silkworm extract powder. The No-Observed-Adverse-Effect-Level (NOAEL) of silkworm extract powder in the 90 day study was 2000 mg/kg/day in both sexes, and no target organ was identified.


Sujets)
Animaux , Souris , Rats , 1-Désoxynojirimycine , Biochimie , Poids , Bombyx , Moelle osseuse , Aberrations des chromosomes , Diabète , Aliment fonctionnel , Nourriture biologique , Hématologie , Tests de micronucleus , Morus , Tests de mutagénicité , Taille d'organe , Rat Sprague-Dawley , Toxicologie , Examen des urines , Consommation de boisson
5.
Laboratory Animal Research ; : 123-129, 2012.
Article Dans Anglais | WPRIM | ID: wpr-98978

Résumé

The purpose of this study was to investigate the anti-hyperlipidemic effect of soy bean extract solution fermented by Bacillus subtilis MORI (BTD-1E) in obese db/db mice. Eight-week-old male db/db mice were administered 33.3 mg/kg BTD-1E solution orally once a day for four weeks. The BTD-1E group showed significantly lower body weight compared with the db control group (P<0.05). The BTD-1E group showed significantly lower serum total cholesterol and LDL cholesterol levels compared with the db control group, respectively (P<0.05, P<0.01). The BTD-1E group showed significantly decreased liver weight relative to final body weight compared with the db control group (P<0.01). After four weeks of BTD-1E administration, lipid droplets in the liver were apparently decreased in the BTD-1E group compared to the db control group. In summary, our results suggest that BTD-1E has an anti-hyperlipidemic effect in the obese mouse model.


Sujets)
Animaux , Humains , Mâle , Souris , 1-Désoxynojirimycine , Bacillus , Bacillus subtilis , Poids , Cholestérol , Cholestérol LDL , Foie , Souris obèse , Glycine max
6.
China Journal of Chinese Materia Medica ; (24): 2102-2106, 2011.
Article Dans Chinois | WPRIM | ID: wpr-283248

Résumé

<p><b>OBJECTIVE</b>To study the correlation of 1-deoxynojirimycin (DNJ) between Taxilli Herba parasitized in mulberry and its host-plants.</p><p><b>METHOD</b>The contents of DNJ of Taxilli Herba parasitized in mulberry and non-mulberry were determined by RP-HPLC. DNJ was extracted with 0.05 mol x L(-1) HCl, and then detected by fluorescence detector after derivatized with FMOC-Cl at pH 8.0 with borate buffer. The separation was performed on an Agilent C18 (4.6 mm x 250 mm, 5 microm) column with a mobile phase of acetonitrile-0.1% aqueous acetic acid (51: 49) at a flow rate of 1.0 mL x min(-1). The wavelength of fluorescence detector was operated at lambda(EX) = 254 nm and lambda(EM) = 322 nm.</p><p><b>RESULT</b>The linear range of DNJ was 3.72-37.2 mg x L(-1) (r = 0.999 9). The average recovery was 96.42%. The contents of DNJ in mulberry and Taxilli Herba parasitized in mulberry were 1.39-10.16 mg x g(-1) and 0.46-2.72 mg x g(-1), respectively. However, the contents of DNJ could not be detected in Taxilli Herba parasitized in non mulberry and its host-plants.</p><p><b>CONCLUSION</b>As the characteristic constituent of mulberry, DNJ was accumulated in Taxilli Herba This method can be applied to the quality control of Taxilli Herba from mulberry.</p>


Sujets)
1-Désoxynojirimycine , Chromatographie en phase liquide à haute performance , Stabilité de médicament , Morus , Chimie , Reproductibilité des résultats
7.
The Korean Journal of Physiology and Pharmacology ; : 251-258, 2011.
Article Dans Anglais | WPRIM | ID: wpr-727876

Résumé

Here we have investigated how lactosylceramide (LacCer) modulates gene expression of adhesion molecules in TNF-alpha and IFNgamma (CM)-stimulated astrocytes. We have observed that stimulation of astrocytes with CM increased the gene expression of ICAM-1 and VCAM-1. D-Threo-1-phenyl- 2-decanoylamino-3-morpholino-1-propanol (PDMP) and N-butyldeoxynojirimycin (NBDNJ), inhibitors of glucosylceramide synthase (GLS) and LacCer synthase (galactosyltransferase, GalT-2), inhibited the gene expression of ICAM-1 and VCAM-1 and activation of their gene promoter induced by CM, which were reversed by exogenously supplied LacCer. Silencing of GalT-2 gene using its antisense oligonucleotides also attenuated CM-induced ICAM-1 and VCAM-1 expression, which were reversed by LacCer. PDMP treatment and silencing of GalT-2 gene significantly reduced CM-induced luciferase activities in NF-KB, AP-1, GAS, and STAT-3 luciferase vectors-transfected cells. In addition, LacCer reversed the inhibition of NF-KB and STAT-1 luciferase activities by PDMP. Taken together, our results suggest that LacCer may play a crucial role in the expression of ICAM-1 and VCAM-1 via modulating transcription factors, such as NF-KB, AP-1, STAT-1, and STAT-3 in CM-stimulated astrocytes.


Sujets)
1-Désoxynojirimycine , Antigènes CD , Astrocytes , Galactosyltransferases , Expression des gènes , Glucosyltransferases , Molécule-1 d'adhérence intercellulaire , Lactosylcéramides , Luciferases , Morpholines , Facteur de transcription NF-kappa B , Oligonucléotides antisens , Facteur de transcription AP-1 , Facteurs de transcription , Facteur de nécrose tumorale alpha , Molécule-1 d'adhérence des cellules vasculaires
8.
Acta Pharmaceutica Sinica ; (12): 347-352, 2010.
Article Dans Anglais | WPRIM | ID: wpr-250651

Résumé

An HPLC-UV method has been developed for the determination of valibose, miglitol, voglibose and acarbose, the four anti-diabetic drugs. The separation was accomplished successfully by using reversed phase chromatography (Prevail carbohydrate column, 250 mm x 4.6 mm, 5 microm) with a gradient acetonitrile-phosphate buffer solution (pH 8.0) at a wavelength of 210 nm. Furthermore, the method of a high-performance liquid chromatography coupled with ESI-MS in positive ionization mode has been established. These two methods were successfully applied to the assay and qualitative detection of four alpha-glucosidase inhibitors in the potential counterfeit anti-diabetic drugs.


Sujets)
1-Désoxynojirimycine , Acarbose , Chromatographie en phase liquide à haute performance , Méthodes , Chromatographie en phase inverse , Inhibiteurs des glycoside hydrolases , Hypoglycémiants , Chimie , Inositol , Spectrométrie de masse ESI , Méthodes , Spectrophotométrie UV , alpha-Glucosidase
9.
China Journal of Chinese Materia Medica ; (24): 402-405, 2009.
Article Dans Chinois | WPRIM | ID: wpr-298392

Résumé

<p><b>OBJECTIVE</b>To study the chemical constituents of Polygala telephioides.</p><p><b>METHOD</b>The compounds were isolated and purified on macroporous resin, silica gel, Sephadex LH-20, Chromatorex ODS column chromatograph and the structures were determined based on the spectral and chemical evidences.</p><p><b>RESULT</b>Four compounds were obtained and characterized as telephiose G, telephiose D, isomangiferin, quescetin 3-O-beta-D-glucopyranoside, respectively.</p><p><b>CONCLUSION</b>Compounds 2-4 were obtained from this plant for the first time and the compound 2 (telephiose G) was a new compound.</p>


Sujets)
1-Désoxynojirimycine , Dextrane , Glucosides , Structure moléculaire , Extraits de plantes , Pharmacologie , Polygala , Chimie , Gel de silice , Silice , Spectrométrie de masse ESI , Xanthones
10.
Experimental & Molecular Medicine ; : 1-7, 2009.
Article Dans Anglais | WPRIM | ID: wpr-43814

Résumé

Fabry disease is an X-linked inborn error of glycosphingolipid catabolism that results from mutations in the gene encoding the alpha-galactosidase A (GLA) enzyme. We have identified 15 distinct mutations in the GLA gene in 13 unrelated patients with classic Fabry disease and 2 unrelated patients with atypical Fabry disease. Two of the identified mutations were novel (i.e., the D231G missense mutation and the L268delfsX1 deletion mutation). This study evaluated the effects of the chemical chaperones 1-deoxygalactonojirimycin (DGJ) on the function of GLA in vitro, in cells containing missense mutations in the GLA gene. Nine missense and a nonsense mutations, including one novel mutation were cloned into mammalian expression vectors. After transient expression in COS-7 cells, GLA enzyme activity and protein expression were analyzed using fluorescence spectrophotometry and Western blot analysis, respectively. DGJ enhanced GLA enzyme activity in the M42V, I91T, R112C and F113L mutants. Interestingly, the I91T and F113L mutations are associated with the atypical form of Fabry disease. However, DGJ treatment did not have any significant effect on the GLA enzyme activity and protein expression of other mutants, including C142W, D231G, D266N, and S297F. Of note, GLA enzyme activity was not detected in the novel mutant (i.e., D231G), although protein expression was similar to the wild type. In the absence of DGJ, the E66Q mutant had wild-type levels of GLA protein expression and approximately 40% GLA activity, indicating that E66Q is either a mild mutation or a functional single nucleotide polymorphism (SNP). Thus, the results of this study suggest that the chemical chaperone DGJ enhances GLA enzyme activity and protein expression in milder mutations associated with the atypical form of Fabry disease.


Sujets)
Adolescent , Adulte , Animaux , Humains , Mâle , Adulte d'âge moyen , Jeune adulte , 1-Désoxynojirimycine/analogues et dérivés , Asiatiques/génétique , Cellules COS , Chlorocebus aethiops , Maladie de Fabry/enzymologie , Expression des gènes , Mutation , alpha-Galactosidase/génétique
11.
J Indian Med Assoc ; 2007 Jun; 105(6): 344, 346, 350
Article Dans Anglais | IMSEAR | ID: sea-96312

Résumé

Postprandial hyperglycaemia and spikes have deleterious effects on Insulin secretion and sensitivity. The present study was undertaken to evaluate the efficacy, safety and tolerability of miglitol 50 mg three times daily for 12 weeks in 129 patients with type 2 diabetes mellitus, inadequately managed with diet and exercise therapy alone for 3 months after obtaining their written informed consent. The primary efficacy variables were per cent change from baseline at week 12 in fasting and postprandial plasma glucose concentrations and glycosylated haemoglobin (HbA(1C)) levels. After treatment at the end of 12 weeks mean reduction in fasting plasma glucose levels was 35.7% and 44.33% in postprandial plasma glucose levels while the mean HbA(1C) was significantly reduced by 0.88% (p<0.05). Total cholesterol, HDL, LDL and TC/HDL ratio did not showed any significant change but a non-significant reduction in triglyceride levels was observed in some patients. The mean body mass index was reduced non-significantly by 8% from baseline values. A total 19.5% patients treated with miglitol reported adverse events like flatulence, abdominal pain, nausea/vomiting, diarrhoea and dyspepsia. Only one patient reported hypoglycaemia. The results of the present study indicate that miglitol reduces fasting and postprandial plasma glucose levels, Improving glycaemic control, which is reflected in a reduced HbA(1C) level in patients with type 2 diabetes mellitus. It could be a useful first-line therapy in patients with type 2 diabetes mellitus inadequately controlled by diet alone and as adjuvant therapy in patients who are inadequately controlled with diet and sulfonylureas.


Sujets)
1-Désoxynojirimycine/effets indésirables , Adolescent , Adulte , Sujet âgé , Diabète de type 2/traitement médicamenteux , Femelle , Humains , Hyperglycémie/traitement médicamenteux , Hypoglycémiants/effets indésirables , Iminopyranoses/effets indésirables , Inde , Mâle , Adulte d'âge moyen , Période post-prandiale , Études prospectives , Facteurs de risque , Résultat thérapeutique
12.
China Journal of Chinese Materia Medica ; (24): 695-698, 2007.
Article Dans Chinois | WPRIM | ID: wpr-283405

Résumé

<p><b>OBJECTIVE</b>To study the chemical constituents from the leaves of Morus multicaulis.</p><p><b>METHOD</b>The compounds were isolated by ion exchange resin, silica gel and Sephadex LH -20 column chromatographies. Their structures were elucidated on the basis of physico-chemical properties and spectral data.</p><p><b>RESULT</b>Twelve compounds were isolated from the leaves of this plant. Their structures were identified as 1-deoxynojirimycin (1), fagomine (2), 2-O-alpha-D-galactopyranosyl-1-deoxynojirimycin (3), quercetin-7-O-beta-D-glucoside (4), kaempferol (5), quercetin (6), scopoletin (7), D-aspartic acid (8), L-proline (9), D-alpha-alanine (10), myo-inositol (11) and dausterol (12).</p><p><b>CONCLUSION</b>All compounds were isolated from this plant for the first time.</p>


Sujets)
1-Désoxynojirimycine , Chimie , Iminopyranoses , Chimie , Kaempférols , Chimie , Morus , Chimie , Pipéridines , Chimie , Feuilles de plante , Chimie , Plantes médicinales , Chimie , Spectrométrie de masse ESI
13.
China Journal of Chinese Materia Medica ; (24): 682-685, 2005.
Article Dans Chinois | WPRIM | ID: wpr-358096

Résumé

<p><b>OBJECTIVE</b>To develop a high performance liquid chromatographic method for the determination of DNJ in Morus alba leaves with fluorimetric detection after precolumn derivatization with 9-fluorenylmnethyl chlorformate (FMOC-Cl).</p><p><b>METHOD</b>DNJ in Morus alba leaves was extracted with 0.05 mol x L(-1) HCl, reacted with FMOC-Cl, and separated on a HiQSiL C18 column at 250 degrees C. Mobile phase consisted of acetonitrile-0.1% aqueous acetic acid (55:45) with a flow rate of 1.0 mL x min. The fluorescence detector was operated at lambdaEX = 254 nm, lambdaEM = 322 nm.</p><p><b>RESULT</b>A satisfactory separation between DNJ and impurity was obtained. The calibration curve was linear over the concentration range from 0.567 microg x mL(-1) to 34 microg mL(-1), r = 0.9998. The average recovery was 97.2%. The contents of DNJ in M. alba collected in different seasons and grown in different environment were determined.</p><p><b>CONCLUSION</b>The quantity of DNJ in leaves of M. alba is related to the environment factor, temperature and growing period. The method can be used for qualioy control of the medicinal material.</p>


Sujets)
1-Désoxynojirimycine , Écosystème , Morus , Chimie , Feuilles de plante , Chimie , Plantes médicinales , Chimie , Contrôle de qualité , Saisons , Température
SÉLECTION CITATIONS
Détails de la recherche